vs
微策略（MSTR）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
微策略的季度营收约是PROCEPT BioRobotics Corp的1.5倍（$123.0M vs $83.1M），PROCEPT BioRobotics Corp同比增速更快（20.2% vs 1.9%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 3.3%）
Strategy Inc（原名为微策略）是1989年成立的美国上市企业，主营商业智能与移动软件业务，旗下产品可帮助企业分析内外部数据以支撑经营决策，还可用于移动应用开发，总部位于弗吉尼亚州泰森斯角，商业分析赛道核心竞品包括SAP等。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
MSTR vs PRCT — 直观对比
营收规模更大
MSTR
是对方的1.5倍
$83.1M
营收增速更快
PRCT
高出18.3%
1.9%
两年增速更快
PRCT
近两年复合增速
3.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $123.0M | $83.1M |
| 净利润 | — | $-31.6M |
| 毛利率 | 66.1% | 64.9% |
| 营业利润率 | — | -4.1% |
| 净利率 | — | -38.1% |
| 营收同比 | 1.9% | 20.2% |
| 净利润同比 | — | -27.9% |
| 每股收益（稀释后） | — | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSTRPRCT
| Q1 26 | — | $83.1M | ||
| Q4 25 | $123.0M | $76.4M | ||
| Q3 25 | $128.7M | $83.3M | ||
| Q2 25 | $114.5M | $79.2M | ||
| Q1 25 | $111.1M | $69.2M | ||
| Q4 24 | $120.7M | $68.2M | ||
| Q3 24 | $116.1M | $58.4M | ||
| Q2 24 | $111.4M | $53.4M |
净利润MSTRPRCT
| Q1 26 | — | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $2.8B | $-21.4M | ||
| Q2 25 | $10.0B | $-19.6M | ||
| Q1 25 | $-4.2B | $-24.7M | ||
| Q4 24 | $-670.8M | $-18.9M | ||
| Q3 24 | $-340.2M | $-21.0M | ||
| Q2 24 | $-102.6M | $-25.6M |
毛利率MSTRPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | 66.1% | 60.6% | ||
| Q3 25 | 70.5% | 64.8% | ||
| Q2 25 | 68.8% | 65.4% | ||
| Q1 25 | 69.4% | 63.9% | ||
| Q4 24 | 71.7% | 64.0% | ||
| Q3 24 | 70.4% | 63.2% | ||
| Q2 24 | 72.2% | 59.0% |
营业利润率MSTRPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | — | -27.8% | ||
| Q2 25 | — | -28.0% | ||
| Q1 25 | -5331.4% | -39.7% | ||
| Q4 24 | -842.1% | -28.9% | ||
| Q3 24 | -372.7% | -38.4% | ||
| Q2 24 | -179.7% | -50.3% |
净利率MSTRPRCT
| Q1 26 | — | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | 2164.1% | -25.7% | ||
| Q2 25 | 8752.7% | -24.7% | ||
| Q1 25 | -3797.2% | -35.8% | ||
| Q4 24 | -555.8% | -27.6% | ||
| Q3 24 | -293.1% | -35.9% | ||
| Q2 24 | -92.0% | -48.0% |
每股收益（稀释后）MSTRPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | — | $-0.54 | ||
| Q3 25 | $8.42 | $-0.38 | ||
| Q2 25 | $32.60 | $-0.35 | ||
| Q1 25 | $-16.49 | $-0.45 | ||
| Q4 24 | $4.49 | $-0.34 | ||
| Q3 24 | $-1.72 | $-0.40 | ||
| Q2 24 | $-0.57 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.3B | $245.6M |
| 总债务越低越好 | $8.2B | $51.7M |
| 股东权益账面价值 | $44.1B | $347.7M |
| 总资产 | $61.6B | $487.1M |
| 负债/权益比越低杠杆越低 | 0.19× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资MSTRPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | $2.3B | $286.5M | ||
| Q3 25 | $54.3M | $294.3M | ||
| Q2 25 | $50.1M | $302.7M | ||
| Q1 25 | $60.3M | $316.2M | ||
| Q4 24 | $38.1M | $333.7M | ||
| Q3 24 | $46.3M | $196.8M | ||
| Q2 24 | $66.9M | $214.1M |
总债务MSTRPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | $8.2B | $51.6M | ||
| Q3 25 | $8.2B | $51.6M | ||
| Q2 25 | $8.2B | $51.5M | ||
| Q1 25 | $8.1B | $51.5M | ||
| Q4 24 | $7.2B | $51.5M | ||
| Q3 24 | $4.2B | $51.4M | ||
| Q2 24 | $3.8B | $51.4M |
股东权益MSTRPRCT
| Q1 26 | — | $347.7M | ||
| Q4 25 | $44.1B | $365.9M | ||
| Q3 25 | $52.3B | $380.3M | ||
| Q2 25 | $47.5B | $385.8M | ||
| Q1 25 | $32.2B | $389.2M | ||
| Q4 24 | $18.2B | $402.2M | ||
| Q3 24 | $3.8B | $241.2M | ||
| Q2 24 | $2.8B | $251.8M |
总资产MSTRPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $61.6B | $508.1M | ||
| Q3 25 | $73.6B | $511.5M | ||
| Q2 25 | $64.8B | $513.1M | ||
| Q1 25 | $43.9B | $519.4M | ||
| Q4 24 | $25.8B | $534.0M | ||
| Q3 24 | $8.3B | $374.1M | ||
| Q2 24 | $7.1B | $374.4M |
负债/权益比MSTRPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.19× | 0.14× | ||
| Q3 25 | 0.16× | 0.14× | ||
| Q2 25 | 0.17× | 0.13× | ||
| Q1 25 | 0.25× | 0.13× | ||
| Q4 24 | 0.39× | 0.13× | ||
| Q3 24 | 1.12× | 0.21× | ||
| Q2 24 | 1.36× | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSTR
暂无分部数据
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
